Quest Diagnostics (NYSE: DGX) SVP reports tax-withholding stock disposition on Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Quest Diagnostics senior executive reports small tax-related share disposition. Michael J. Deppe, SVP, Corporate Controller and Chief Accounting Officer of Quest Diagnostics, had 88 shares of common stock withheld at $204.86 per share on a Form 4 event dated March 2, 2026 to satisfy tax obligations from previously vested restricted share units, rather than an open-market sale. After this transaction, he directly held 34,473 shares of Quest Diagnostics common stock. The filing also notes indirect ownership of 706 shares through the company’s 401(k) Profit Sharing Plan, with balances based on plan administrator data.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Deppe Michael J
Role
SVP, Corp. Controller & CAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 88 | $204.86 | $18K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 34,473 shares (Direct);
Common Stock — 706 shares (Indirect, 401(k))
Footnotes (1)
- Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
FAQ
What did Quest Diagnostics (DGX) executive Michael J. Deppe report on this Form 4?
Michael J. Deppe reported a tax-withholding disposition of 88 shares of Quest Diagnostics common stock. The shares were used to cover tax obligations from the vesting of previously granted restricted share units, rather than sold in an open-market transaction.
Was the Quest Diagnostics (DGX) Form 4 transaction an open-market sale by the executive?
No. The Form 4 describes a tax-withholding disposition, not a discretionary open-market sale. Shares were delivered to satisfy tax obligations triggered by the vesting of restricted share units, as detailed in the filing’s explanatory footnote.